Controlled Fluid Removal in Critical Ill Patients With Fluid Overload in the Intensive Care Unit.
Status:
Recruiting
Trial end date:
2024-11-17
Target enrollment:
Participant gender:
Summary
This study evaluates the benefits and harms of goal directed fluid removal with furosemide
versus placebo in critical ill adult patients with fluid overload in the intensive care unit.
Half of the patients will receive furosemide and the other half placebo. The treatment will
continue until the excess fluid is excreted.
Phase:
Phase 4
Details
Lead Sponsor:
Morten H. Bestle
Collaborators:
Centre for Research in Intensive Care (CRIC) Copenhagen Trial Unit, Center for Clinical Intervention Research Director Jakob Madsen´s and wife Olga Madsen´s foundation Novo Nordisk A/S University of Copenhagen